Lipocine Inc(LPCN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LPCN Lipocine Inc

交易中 04-10 10:09:31 EDT

2.11

+0.02

+0.96%

最高2.16	最低2.11	成交量9.21万
今开2.12	昨收2.09	日振幅2.39%
总市值1,540万	流通市值1,395万	总股本729.97万
成交额19.58万	换手率1.39%	流通股本661.19万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"LPCN","market":"US","secType":"STK","nameCN":"Lipocine Inc","latestPrice":2.11,"timestamp":1775830031616,"preClose":2.09,"halted":0,"volume":92122,"delay":0,"changeRate":0.00956937799043063,"floatShares":6611900,"shares":7299687,"eps":-1.76688,"marketStatus":"交易中","change":0.02,"latestTime":"04-10 10:09:31 EDT","open":2.12,"high":2.16,"low":2.11,"amount":195784.0492424,"amplitude":0.023923,"askPrice":2.12,"askSize":1514,"bidPrice":2.11,"bidSize":3944,"shortable":3,"etf":0,"ttmEps":-1.76688,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1775851200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1395374400000,"exchange":"NASDAQ","adjPreClose":2.09,"preHourTrading":{"tag":"盘前","latestPrice":2.11,"preClose":2.09,"latestTime":"09:24 EDT","volume":4630,"amount":9751.486074999999,"timestamp":1775827450480,"change":0.02,"changeRate":0.009569,"amplitude":0.052632},"postHourTrading":{"tag":"盘后","latestPrice":2.1299,"preClose":2.09,"latestTime":"19:53 EDT","volume":10477,"amount":22154.6746,"timestamp":1775778820065,"change":0.0399,"changeRate":0.019091,"amplitude":0.02866},"volumeRatio":0.310597,"impliedVol":2.2886,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/LPCN","defaultTab":"news","newsList":[{"id":"1189923679","title":"Lipocine产后抑郁症药物三期试验未达主要终点 股价暴跌78.1%创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=1189923679","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189923679?lang=zh_cn&edition=full","pubTime":"2026-04-02 21:41","pubTimestamp":1775137309,"startTime":"0","endTime":"0","summary":"Lipocine Inc（纳斯达克：LPCN）股价遭遇断崖式下跌，盘中一度触及历史最低点。该公司研发的产后抑郁症治疗药物在三期临床试验中未能达到主要研究终点，引发投资者大规模抛售。\n截至收盘，Lipocine股价暴跌78.1%，创下该公司上市以来最大单日跌幅。这一惨淡表现彻底抹去了该股年内全部涨幅，市值蒸发超过四分之三。\n临床数据显示，该口服药物在改善产后抑郁症患者症状方面与安慰剂相比未呈现显著统计学差异。受此利空冲击，多家华尔街机构随即下调该股评级，并大幅调降目标股价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167623844","title":"Lipocine产后抑郁症药物三期试验未达主要终点 股价盘前暴跌78.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167623844","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167623844?lang=zh_cn&edition=full","pubTime":"2026-04-02 20:55","pubTimestamp":1775134537,"startTime":"0","endTime":"0","summary":"Lipocine Inc（股票代码：LPCN）宣布其针对产后抑郁症的试验性药物未能达到三期临床试验的主要终点，导致公司股价在盘前交易中重挫78.4%。这一重大挫折令投资者感到意外，并对该药物的未来前景产生质疑。\n此次试验结果的失败，不仅影响了股价表现，也可能对Lipocine公司后续的研发计划和资金状况构成挑战。市场正在密切关注公司管理层是否会调整研发策略或寻求其他合作机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164012994","title":"Lipocine公布LPCN 1154治疗产后抑郁症患者的主要安全性与有效性结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1164012994","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164012994?lang=zh_cn&edition=full","pubTime":"2026-04-02 20:02","pubTimestamp":1775131370,"startTime":"0","endTime":"0","summary":"Lipocine Inc公布了其研究药物LPCN 1154针对产后抑郁症患者所取得的主要安全性与有效性试验结果。该数据揭示了该疗法在此患者群体中的表现，为后续研发提供了关键依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102788056","title":"Lipocine宣布LPCN 1154治疗产后抑郁症关键三期试验完成末例患者访视","url":"https://stock-news.laohu8.com/highlight/detail?id=1102788056","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102788056?lang=zh_cn&edition=full","pubTime":"2026-02-18 21:01","pubTimestamp":1771419676,"startTime":"0","endTime":"0","summary":"生物制药公司Lipocine Inc宣布，其用于治疗产后抑郁症（PPD）的在研药物LPCN 1154，其关键性第三阶段临床试验已完成最后一例患者的最终访视。这一重要里程碑标志着该试验患者参与阶段已顺利结束，公司下一步将进行数据整理与分析，为后续向监管机构提交申请奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134701897","title":"Lipocine第三季度每股收益为-0.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134701897","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134701897?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571457,"startTime":"0","endTime":"0","summary":"11月6日 - Lipocine第三季度基本每股收益为-0.59美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159082608","title":"Lipocine Inc：药物安全监测委员会会议评估三分之一计划参与者，研究将按计划继续进行","url":"https://stock-news.laohu8.com/highlight/detail?id=1159082608","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159082608?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:02","pubTimestamp":1763470937,"startTime":"0","endTime":"0","summary":"Lipocine Inc：药物安全监测委员会会议评估三分之一计划参与者，研究将按计划继续进行","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184900780","title":"Lipocine在Lpcn 1154治疗产后抑郁症的三期试验中强调了有希望的中期安全性特征","url":"https://stock-news.laohu8.com/highlight/detail?id=1184900780","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184900780?lang=zh_cn&edition=full","pubTime":"2025-11-18 21:01","pubTimestamp":1763470880,"startTime":"0","endTime":"0","summary":"Lipocine在Lpcn 1154治疗产后抑郁症的三期试验中强调了有希望的中期安全性特征","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581211720","title":"Lipocine Inc.盘中异动 股价大涨5.47%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581211720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581211720?lang=zh_cn&edition=full","pubTime":"2025-11-06 22:47","pubTimestamp":1762440457,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日22时47分，Lipocine Inc.股票出现波动，股价急速拉升5.47%。截至发稿，该股报2.70美元/股，成交量8526股，换手率0.16%，振幅3.13%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106224737a48db565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106224737a48db565&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577334974","title":"Lipocine Inc.盘中异动 急速跳水5.46%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577334974","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577334974?lang=zh_cn&edition=full","pubTime":"2025-10-23 01:11","pubTimestamp":1761153077,"startTime":"0","endTime":"0","summary":"北京时间2025年10月23日01时11分，Lipocine Inc.股票出现波动，股价快速下挫5.46%。截至发稿，该股报2.77美元/股，成交量4.0275万股，换手率0.74%，振幅5.46%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司，致力于利用其专有药物递送技术研发药物递送解决方案。Lipocine 既自行研发候选药物，也代表或与企业合作伙伴合作开发候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023011117973cf4a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023011117973cf4a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518207789","title":"Lipocine Inc.盘中异动 下午盘股价大跌5.19%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518207789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518207789?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:10","pubTimestamp":1741630236,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时10分，Lipocine Inc.股票出现波动，股价急速跳水5.19%。截至发稿，该股报3.26美元/股，成交量7167股，换手率0.13%，振幅4.36%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Aeon Biopharma, Inc.、Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃，换手率分别为5737.61%、3831.85%、995.55%，振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc，振幅分别为90.44%、88.14%、58.34%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102103698a2d3d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102103698a2d3d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517651941","title":"Lipocine Inc.盘中异动 股价大涨5.86%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517651941","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517651941?lang=zh_cn&edition=full","pubTime":"2025-03-06 00:28","pubTimestamp":1741192105,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时28分，Lipocine Inc.股票出现异动，股价急速上涨5.86%。截至发稿，该股报3.25美元/股，成交量3538股，换手率0.07%，振幅6.51%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Chimerix, Inc.、Nutriband Inc C/Wts 、Radiopharm Theranostics Limited涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为907.09%、294.35%、279.53%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为82.59%、54.27%、41.26%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306002826abe9d484&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306002826abe9d484&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514705249","title":"Lipocine Inc.盘中异动 股价大跌6.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514705249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514705249?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:50","pubTimestamp":1740430236,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时50分，Lipocine Inc.股票出现异动，股价急速跳水6.80%。截至发稿，该股报3.15美元/股，成交量1.3591万股，换手率0.25%，振幅5.47%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为332.10%、145.14%、41.60%，振幅较大的相关个股有Nutriband Inc C/Wts 、Pepgen Inc.、Surrozen Inc C/Wts 01/08/2031 ，振幅分别为176.22%、164.23%、81.92%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225045036abdb5d2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225045036abdb5d2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513221409","title":"Lipocine Inc.盘中异动 急速下跌5.29%报3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513221409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513221409?lang=zh_cn&edition=full","pubTime":"2025-02-22 04:19","pubTimestamp":1740169141,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日04时19分，Lipocine Inc.股票出现波动，股价大幅跳水5.29%。截至发稿，该股报3.40美元/股，成交量1.1469万股，换手率0.21%，振幅1.67%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.27%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Moolec Science Sa C/Wts 、Invivyd, Inc.涨幅较大，Aditxt, Inc.、Nkgen Biotech, Inc.、Osr Holdings, Inc.较为活跃，换手率分别为320.00%、252.20%、138.31%，振幅较大的相关个股有Osr Holdings, Inc.、Invivyd, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为76.52%、70.25%、61.26%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222041901988e25de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222041901988e25de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512616509","title":"Lipocine Inc.盘中异动 急速跳水5.91%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512616509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512616509?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:33","pubTimestamp":1739889206,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时33分，Lipocine Inc.股票出现异动，股价大幅跳水5.91%。截至发稿，该股报3.42美元/股，成交量4008股，换手率0.07%，振幅3.71%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为280.57%、97.57%、73.65%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Solid Biosciences Inc.，振幅分别为34.04%、22.30%、18.61%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223326a24aad39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223326a24aad39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509775337","title":"Lipocine Inc.盘中异动 下午盘股价大跌5.73%报3.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509775337","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509775337?lang=zh_cn&edition=full","pubTime":"2025-02-08 03:49","pubTimestamp":1738957741,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日03时49分，Lipocine Inc.股票出现波动，股价急速下跌5.73%。截至发稿，该股报3.56美元/股，成交量2.6097万股，换手率0.49%，振幅7.39%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Conduit Pharmaceuticals Inc.、Surrozen Inc C/Wts 01/08/2031 、Sionna Therapeutics, Inc.涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为8585.83%、182.10%、146.67%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、93.55%、56.78%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208034902987de33d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208034902987de33d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509272467","title":"Lipocine Inc.盘中异动 早盘快速跳水5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509272467","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509272467?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:32","pubTimestamp":1738852370,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时32分，Lipocine Inc.股票出现异动，股价快速下挫5.76%。截至发稿，该股报4.18美元/股，成交量2.9858万股，换手率0.56%，振幅3.39%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Lipella Pharmaceuticals Inc.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Immatics N V C/Wts 01/07/2025 涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3923.31%、348.15%、115.33%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Rani Therapeutics Holdings, Inc.、Relmada Therapeutics, Inc.，振幅分别为33.33%、18.06%、16.76%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223251a23bce9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223251a23bce9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508490811","title":"Lipocine Inc.盘中异动 早盘股价大涨6.48%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508490811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508490811?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593228,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，Lipocine Inc.股票出现异动，股价大幅拉升6.48%。截至发稿，该股报4.60美元/股，成交量3380股，换手率0.06%，振幅4.40%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为343.68%、274.92%、131.63%，振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.，振幅分别为57.05%、33.33%、22.28%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223348a2380a19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223348a2380a19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506512002","title":"Lipocine Inc.盘中异动 早盘股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506512002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506512002?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:12","pubTimestamp":1738077132,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时12分，Lipocine Inc.股票出现异动，股价快速上涨5.53%。截至发稿，该股报4.77美元/股，成交量1822股，换手率0.03%，振幅3.21%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Silexion Therapeutics Corp、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Hepion Pharmaceuticals, Inc.涨幅较大，Silexion Therapeutics Corp、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为3145.85%、1997.38%、567.00%，振幅较大的相关个股有Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Silexion Therapeutics Corp、Transcode Therapeutics, Inc.，振幅分别为122.16%、68.95%、58.57%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128231213abbb6f1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128231213abbb6f1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LPCN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506308922","title":"Lipocine Inc.盘中异动 股价大涨8.64%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506308922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506308922?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:33","pubTimestamp":1737988408,"startTime":"0","endTime":"0","summary":"北京时间2025年01月27日22时33分，Lipocine Inc.股票出现波动，股价快速上涨8.64%。截至发稿，该股报5.10美元/股，成交量3269股，换手率0.06%，振幅5.22%。Lipocine Inc.股票所在的生物技术行业中，整体涨幅为0.41%。其相关个股中，Akero Therapeutics, Inc.、89Bio, Inc.、Onconetix, Inc.涨幅较大，Onconetix, Inc.、Pmgc Holdings Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为722.71%、42.91%、37.98%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Evaxion Biotech As、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为50.00%、18.91%、15.24%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223328abba5ff5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127223328abba5ff5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506215818","title":"Lipocine Inc.盘中异动 下午盘股价大涨6.28%报4.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506215818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506215818?lang=zh_cn&edition=full","pubTime":"2025-01-25 04:27","pubTimestamp":1737750426,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日04时27分，Lipocine Inc.股票出现异动，股价快速拉升6.28%。截至发稿，该股报4.83美元/股，成交量1.0933万股，换手率0.20%，振幅7.16%。Lipocine Inc.股票所在的生物技术行业中，整体跌幅为0.68%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Dermata Therapeutics Inc C/Wts 、Pmgc Holdings Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4639.55%、2422.77%、1769.43%，振幅较大的相关个股有Neuphoria Therapeutics Inc.、Celularity Inc C/Wts 16/07/2026 、Evaxion Biotech As，振幅分别为261.67%、251.21%、137.09%。Lipocine Inc.公司简介：Lipocine Inc 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125042706960fc410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125042706960fc410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LPCN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lipocine.com","stockEarnings":[{"period":"1week","weight":0.0195},{"period":"1month","weight":-0.7423},{"period":"3month","weight":-0.7391},{"period":"6month","weight":-0.3258},{"period":"1year","weight":-0.317},{"period":"ytd","weight":-0.7397}],"compareEarnings":[{"period":"1week","weight":0.0367},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0204},{"period":"6month","weight":0.0412},{"period":"1year","weight":0.2393},{"period":"ytd","weight":-0.0029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lipocine Inc.在1997年6月19日注册于特拉华州，公司是一家专业化生物制药公司，致力于其口服给药技术在生物制药领域的应用和发展。Lipocine公司的专有给药技术通过口服治疗方案以提高患者的依从性和安全性。公司的主要开发项目面向吸收效果差的口服药解决方案，这一类药吸收效果较差，剂量不足以使药效发挥到循环系统。公司有一系列专利候选产品，具有以下特点：具有良好的药代动力学特性、有利于满足低剂量要求、绕过初步的代谢过程、减少副作用、消除了限制药物活性的胃肠道相互作用。公司的候选产品LPCN1021是一个第三准备阶段的口服睾酮替代治疗药（TRT），剂量为一天使用两次，十分方便。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.047924},{"month":2,"riseRate":0.666667,"avgChangeRate":0.075698},{"month":3,"riseRate":0.416667,"avgChangeRate":0.00114},{"month":4,"riseRate":0.384615,"avgChangeRate":-0.110728},{"month":5,"riseRate":0.416667,"avgChangeRate":0.023149},{"month":6,"riseRate":0.666667,"avgChangeRate":0.059734},{"month":7,"riseRate":0.583333,"avgChangeRate":0.061431},{"month":8,"riseRate":0.333333,"avgChangeRate":0.008739},{"month":9,"riseRate":0.25,"avgChangeRate":-0.065749},{"month":10,"riseRate":0.25,"avgChangeRate":-0.080769},{"month":11,"riseRate":0.666667,"avgChangeRate":0.007974},{"month":12,"riseRate":0.416667,"avgChangeRate":0.08663}],"exchange":"NASDAQ","name":"Lipocine Inc","nameEN":"Lipocine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lipocine Inc(LPCN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lipocine Inc(LPCN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lipocine Inc,LPCN,Lipocine Inc股票,Lipocine Inc股票老虎,Lipocine Inc股票老虎国际,Lipocine Inc行情,Lipocine Inc股票行情,Lipocine Inc股价,Lipocine Inc股市,Lipocine Inc股票价格,Lipocine Inc股票交易,Lipocine Inc股票购买,Lipocine Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lipocine Inc(LPCN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lipocine Inc(LPCN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}